Cargando…
IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?
Inflammatory bowel diseases (IBDs) are chronic disorders of the gastrointestinal tract. The goal of IBD treatment is to reduce the inflammation period and induce long-term remission. Use of anti-inflammatory drugs including corticosteroids, immunosuppressants and biologicals, is often the first step...
Autores principales: | Ghavami, Shaghayegh Baradaran, Shahrokh, Shabnam, Hossein-Khannazer, Nikoo, Shpichka, Anastasia, Asadzadeh Aghdaei, Hamid, Timashev, Peter, Vosough, Massoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481906/ https://www.ncbi.nlm.nih.gov/pubmed/32779446 http://dx.doi.org/10.22074/cellj.2020.7603 |
Ejemplares similares
-
Novel therapeutic approaches for treatment of COVID-19
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2020) -
An update to “novel therapeutic approaches for treatment of COVID-19”
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021) -
Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021) -
Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
por: Khoramjoo, Seyed Mobin, et al.
Publicado: (2022) -
Toll-Like Receptor 7 a Novel Non-Invasive Inflammatory Genetic Sensor for Ulcerative Colitis Remission Monitoring
por: Asadzadeh-Aghdaei, Hamid, et al.
Publicado: (2023)